Mereo BioPharma (MREO) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts MREO Hot Sheet
Price: $0.29 -3.33%
Financial Fact:
(Loss) from operations: -144.23K
Today's EPS Names:
ALZN, ASPU, OCCI, More
Financial Fact:
(Loss) from operations: -144.23K
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Mereo BioPharma (NASDAQ: MREO) reported Q2 EPS of ($0.01), in-line with the analyst estimate of ($0.01).
For earnings history and earnings-related data on Mereo BioPharma (MREO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GameStop CEO Cohen buys 1.15M shares
- Lilly breaks ground on $6.5B Houston drug manufacturing site
- Iambic Therapeutics (IAM) files for proposed IPO
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
